This announcement is a separate document:
2022年深圳微芯生物科技股份有限公司向不特定对象发行可转换公司债券2024年跟踪评级报告
In 2022, Shenzhen Chipscreen Biosciences Co., Ltd. issued convertible corporate bonds to unspecified investors. The tracking rating report is for 2024.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.